‹Return to Search Results

Drug Details

Drug Number:	441/08
Drug Name:	lenalidomide (Revlimid)
Drug Manufacturer:	Celgene Ltd
BNF Category:	Malignant disease and immunosuppression
Submission type :	Full submission
Date Advice Issued:	12 May 2008
Indication:	Multiple myeloma

Drug Advice

lenalidomide (Revlimid)

Press Statement

Read the press statement

Read the briefing note

Minutes

Read the minutes

Notes

‹Return to Search Results

Other SMC Advice for this Drug

There is currently no other SMC advice for this product

SEARCH FOR A DRUG

UNKNOWN - All BNF Categories - AnaesthesiaCardiovascular systemCentral nervous systemEar, nose and oropharynxEndocrine systemEyeGastro-intestinal systemImmunological products and vaccinesInfectionsMalignant disease and immunosuppressionMusculoskeletal and joint diseasesNutrition and bloodObstetrics, gynaecology, and urinary-tract disordersRespiratory systemSkin

UNKNOWN - All Types of Submission - Abbreviated SubmissionFull submissionIRPNon submissionResubmission

Help on how to improve your search.